The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 MDS & MPN Update - Luspatercept in Lower-Risk MDS & Ruxolitinib Study + PI3K in Myelofibrosis

88 views
August 2, 2019
Comments 0
Login to view comments. Click here to Login